Of particular interest, SCD1 abundance and activity are highly elevated in macrophages and microglia in active brain lesions of MS patients, and loss and inhibition of SCD1 improves brain repair in toxin-induced ex vivo and in vivo models for demyelination [38]. This evidence concerns the gene SCD and myeloid sarcoma.